Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.184 (
LasR
)
897
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pseudomonas aeruginosa
is among the top three gram-negative bacteria according to the WHO's critical priority list of pathogens against which newer antibiotics are urgently needed and considered a global threat due to multiple drug resistance. This situation demands unconventional antimicrobial strategies such as the inhibition of quorum sensing to alleviate the manifestation of classical resistance mechanisms. Here, we report that 2,4-di-tert-butylphenol (2,4-
DBP
), isolated from an endophytic fungus,
Daldinia eschscholtzii
, inhibits the quorum-sensing properties of
P. aeruginosa.
We have found that treating
P. aeruginosa
with 2,4-
DBP
substantially reduced the secretion of virulence factors as well as biofilm, and its associated factors that are controlled by quorum sensing, in a dose-dependent manner. Concomitantly, 2,4-
DBP
also significantly reduced the expression of quorum sensing-related genes, i.e.,
lasI
,
lasR
,
rhlI
, and
rhlR
significantly. Importantly, 2,4-
DBP
restricted the adhesion and invasion of
P. aeruginosa
to the A549 lung alveolar carcinoma cells. In addition, bactericidal assay with 2,4-
DBP
exhibited synergism with ampicillin to kill
P. aeruginosa.
Furthermore, our computational studies predicted that 2,4-
DBP
could bind to the
P. aeruginosa
quorum-sensing receptors
LasR
and RhlR. Collectively, these data suggest that 2,4-
DBP
can be exploited as a standalone drug or in combination with antibiotic(s) as an anti-virulence and anti-biofilm agent to combat the multidrug resistant
P. aeruginosa
infection.
...
PMID:2,4-Di-Tert-Butylphenol Isolated From an Endophytic Fungus,
Daldinia eschscholtzii
, Reduces Virulence and Quorum Sensing in
Pseudomonas aeruginosa
. 3284 44